(Q37809850)

English

Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection

scientific article published on December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Atripla®): a review of its use in the management of HIV infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Caroline M Perry

2

object named as

Caroline M Perry

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

object named as

Emma D Deeks

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

2315-2338

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Emtricitabine/tenofovir disoproxil fumarate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal dysfunction and tenofovir toxicity in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir disoproxil fumarate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral regimens for treatment-experienced patients with HIV-1 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emtricitabine: a review of its use in the management of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapy and management of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiviral drug-induced nephrotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Universal access to HIV/AIDS treatment: challenges ahead.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of once-daily regimens in the treatment of HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations of current HIV therapies: opportunities for improvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21080746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11203800-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37809850&oldid=2200972672"